Effects of Covid-19 Vaccination during Pregnancy on the Obstetric and Neonatal Outcomes in a Tertiary Health Care Center

1. Guidance for Management of Pregnant Women in COVID-19 Pandemic. Mumbai, India: ICMR - National Institute for Research in Reproductive Health, 2020 Apr 12. Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women in_COVID19_Pandemic_12042020.pdf Guidance for Management of Pregnant Women in COVID-19 Pandemic Mumbai, India ICMR - National Institute for Research in Reproductive Health 2020 Apr 12 Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women in_COVID19_Pandemic_12042020.pdf Search in Google Scholar

2. World Health Organization. Coronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal period. Updated 15 March 2022. Q&A. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-pregnancy-and-childbirth World Health Organization Coronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal period Updated 15 March 2022. Q&A. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-pregnancy-and-childbirth Search in Google Scholar

3. Kucirka LM, Norton A, Sheffield JS. Severity of COVID-19 in pregnancy: A review of current evidence. Am J Reprod Immunol. 2020;84(5):e13332. doi: 10.1111/aji.13332 KucirkaLM NortonA SheffieldJS Severity of COVID-19 in pregnancy: A review of current evidence Am J Reprod Immunol 2020 84 5 e13332 10.1111/aji.13332 Open DOISearch in Google Scholar

4. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292–7. doi: 10.1016/j.ajog.2003.11.019 WongSF ChowKM LeungTN NgWF NgTK ShekCC Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Am J Obstet Gynecol 2004 191 1 292 7 10.1016/j.ajog.2003.11.019 Open DOISearch in Google Scholar

5. Azinheira Nobrega Cruz N, Stoll D, Casarini DE, Bertagnolli M. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility. Clin Sci (Lond). 2021;135(15):1805–24. doi: 10.1042/CS20210284 Azinheira Nobrega CruzN StollD CasariniDE BertagnolliM Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility Clin Sci (Lond) 2021 135 15 1805 24 10.1042/CS20210284 Open DOISearch in Google Scholar

6. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271–80.e8. doi: 10.1016/j.cell.2020.02.052 HoffmannM Kleine-WeberH SchroederS KrügerN HerrlerT ErichsenS SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Cell 2020 181 2 271 80.e8 10.1016/j.cell.2020.02.052 Open DOISearch in Google Scholar

7. Valdés G, Neves LA, Anton L, Corthorn J, Chacón C, Germain AM, et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. 2006;27(2–3):200–7. doi: 10.1016/j.placenta.2005.02.015 ValdésG NevesLA AntonL CorthornJ ChacónC GermainAM Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies Placenta 2006 27 2–3 200 7 10.1016/j.placenta.2005.02.015 Open DOISearch in Google Scholar

8. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al.; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320; Update in: BMJ. 2022 May 30;377:o1205 AlloteyJ StallingsE BonetM YapM ChatterjeeS KewT for PregCOV-19 Living Systematic Review Consortium Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis BMJ 2020 Sep 1 370 m3320 10.1136/bmj.m3320 Update in: BMJ. 2022 May 30;377:o1205 Open DOISearch in Google Scholar

9. Centre for Disease Control and Prevention. COVID-19 vaccines: interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. 2021. Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html or CDC Centre for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Last updated July 20, 2022. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html Centre for Disease Control and Prevention COVID-19 vaccines: interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States 2021 Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html or CDC Centre for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Last updated July 20, 2022. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html Search in Google Scholar

10. Januszewski M, Ziuzia-Januszewska L, Jakimiuk AA, Wierzba W, Gluszko A, Zytynska-Daniluk J, et al. Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study. Int J Environ Res Public Health. 2021;18(22):12011. doi: 10.3390/ijerph182212011 JanuszewskiM Ziuzia-JanuszewskaL JakimiukAA WierzbaW GluszkoA Zytynska-DanilukJ Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study Int J Environ Res Public Health 2021 18 22 12011 10.3390/ijerph182212011 Open DOISearch in Google Scholar

11. Balachandren N, Davies MC, Hall JA, Stephenson JM, David AL, Barrett G, et al. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic. Hum Reprod. 2022;37(6):1126–33. doi: 10.1093/humrep/deac062 BalachandrenN DaviesMC HallJA StephensonJM DavidAL BarrettG SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic Hum Reprod 2022 37 6 1126 33 10.1093/humrep/deac062 Open DOISearch in Google Scholar

12. Sivanandan S, Chawla D, Kumar P; National Neonatology Forum of India (NNF), Federation of Obstetric and Gynaecological Societies of India (FOGSI), and Indian Academy of Pediatrics (IAP). Update to Perinatal-Neonatal Management of COVID-19 Guidelines. Indian Pediatr. 2022;59(1):63–6. doi: 10.1007/s13312-022-2423-7 SivanandanS ChawlaD KumarP National Neonatology Forum of India (NNF), Federation of Obstetric and Gynaecological Societies of India (FOGSI), and Indian Academy of Pediatrics (IAP) Update to Perinatal-Neonatal Management of COVID-19 Guidelines Indian Pediatr 2022 59 1 63 6 10.1007/s13312-022-2423-7 Open DOISearch in Google Scholar

13. Zauche LH, Wallace B, Smoots AN, Olson CK, Oduyebo T, Kim SY, et al.; CDC v-safe Covid-19 Pregnancy Registry Team. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N Engl J Med. 2021;385(16):1533–5. doi: 10.1056/NEJMc2113891 ZaucheLH WallaceB SmootsAN OlsonCK OduyeboT KimSY CDC v-safe Covid-19 Pregnancy Registry Team Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion N Engl J Med 2021 385 16 1533 5 10.1056/NEJMc2113891 Open DOISearch in Google Scholar

14. Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al.; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021 Jun 17;384(24):2273–82. doi: 10.1056/NEJMoa2104983. Erratum in: N Engl J Med. 2021 Oct 14;385(16):1536 ShimabukuroTT KimSY MyersTR MoroPL OduyeboT PanagiotakopoulosL CDC v-safe COVID-19 Pregnancy Registry Team Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons N Engl J Med 2021 Jun 17 384 24 2273 82 10.1056/NEJMoa2104983 Erratum in: N Engl J Med. 2021 Oct 14;385(16):1536 Open DOISearch in Google Scholar

15. World Health Organization. Coronavirus disease (COVID-19): Vaccines. Q&A. Last updated 17 May 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines World Health Organization Coronavirus disease (COVID-19): Vaccines. Q&A Last updated 17 May 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines Search in Google Scholar

16. Rottenstreich M, Sela HY, Rotem R, Kadish E, Wiener-Well Y, Grisaru-Granovsky S. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study. BJOG. 2022;129(2):248–55. doi: 10.1111/1471-0528.16941 RottenstreichM SelaHY RotemR KadishE Wiener-WellY Grisaru-GranovskyS Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study BJOG 2022 129 2 248 55 10.1111/1471-0528.16941 Open DOISearch in Google Scholar

17. Peretz-Machluf R, Hirsh-Yechezkel G, Zaslavsky-Paltiel I, Farhi A, Avisar N, Lerner-Geva L, et al. Obstetric and Neonatal Outcomes following COVID-19 Vaccination in Pregnancy. J Clin Med. 2022;11(9):2540. doi: 10.3390/jcm11092540 Peretz-MachlufR Hirsh-YechezkelG Zaslavsky-PaltielI FarhiA AvisarN Lerner-GevaL Obstetric and Neonatal Outcomes following COVID-19 Vaccination in Pregnancy J Clin Med 2022 11 9 2540 10.3390/jcm11092540 Open DOISearch in Google Scholar

18. Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, et al. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. 2020 Aug;25:100446. doi: 10.1016/j.eclinm.2020.100446 KhalilA KalafatE BenliogluC O’BrienP MorrisE DraycottT SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes EClinicalMedicine 2020 Aug 25 100446 10.1016/j.eclinm.2020.100446 Open DOISearch in Google Scholar

19. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al.; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–7. doi: 10.15585/mmwr.mm6944e3 ZambranoLD EllingtonS StridP GalangRR OduyeboT TongVT CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22–October 3, 2020 MMWR Morb Mortal Wkly Rep 2020 69 44 1641 7 10.15585/mmwr.mm6944e3 Open DOISearch in Google Scholar

20. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540–E548. doi: 10.1503/cmaj.202604 WeiSQ Bilodeau-BertrandM LiuS AugerN The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis CMAJ 2021 193 16 E540 E548 10.1503/cmaj.202604 Open DOISearch in Google Scholar

21. Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021;27(10):1693–5. doi: 10.1038/s41591-021-01490-8 DaganN BardaN Biron-ShentalT Makov-AssifM KeyC KohaneIS Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy Nat Med 2021 27 10 1693 5 10.1038/s41591-021-01490-8 Open DOISearch in Google Scholar

22. Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA. 2021;326(8):728–35. doi: 10.1001/jama.2021.11035 GoldshteinI NevoD SteinbergDM RotemRS GorfineM ChodickG Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women JAMA 2021 326 8 728 35 10.1001/jama.2021.11035 Open DOISearch in Google Scholar

23. Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225(3):303.e1–303.e17. doi: 10.1016/j.ajog.2021.03.023 GrayKJ BordtEA AtyeoC DerisoE AkinwunmiB YoungN Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study Am J Obstet Gynecol 2021 225 3 303.e1 303.e17 10.1016/j.ajog.2021.03.023 Open DOISearch in Google Scholar

24. Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, et al. COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol. 2022;226(2):236.e1–236.e14. doi: 10.1016/j.ajog.2021.08.007 BlakewayH PrasadS KalafatE HeathPT LadhaniSN Le DoareK COVID-19 vaccination during pregnancy: coverage and safety Am J Obstet Gynecol 2022 226 2 236.e1 236.e14 10.1016/j.ajog.2021.08.007 Open DOISearch in Google Scholar

25. Peepal P, Rath TS, Nayak S, Pendyala S. Maternal and neonatal outcomes among women with and without severe acute respiratory syndrome corona virus-2 infection: A retrospective analytical study. J Mother Child. 2021;25(2):77–85. doi: 10.34763/jmotherandchild.20212502.d-21-00021 PeepalP RathTS NayakS PendyalaS Maternal and neonatal outcomes among women with and without severe acute respiratory syndrome corona virus-2 infection: A retrospective analytical study J Mother Child 2021 25 2 77 85 10.34763/jmotherandchild.20212502.d-21-00021 Open DOISearch in Google Scholar

26. Karasek D, Baer RJ, McLemore MR, Bell AJ, Blebu BE, Casey JA, et al. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California. Lancet Reg Health Am. 2021 Oct;2:100027. doi: 10.1016/j.lana.2021.100027 KarasekD BaerRJ McLemoreMR BellAJ BlebuBE CaseyJA The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California Lancet Reg Health Am 2021 Oct 2 100027 10.1016/j.lana.2021.100027 Open DOISearch in Google Scholar

27. Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu J, et al. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(1):26–30. doi: 10.15585/mmwr.mm7101e1 LipkindHS Vazquez-BenitezG DeSilvaM VescoKK Ackerman-BanksC ZhuJ Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021 MMWR Morb Mortal Wkly Rep 2022 71 1 26 30 10.15585/mmwr.mm7101e1 Open DOISearch in Google Scholar

28. Dick A, Rosenbloom JI, Gutman-Ido E, Lessans N, Cahen-Peretz A, Chill HH. Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study. BMC Pregnancy Childbirth. 2022;22(1):166. doi: 10.1186/s12884-022-04505-5 DickA RosenbloomJI Gutman-IdoE LessansN Cahen-PeretzA ChillHH Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study BMC Pregnancy Childbirth 2022 22 1 166 10.1186/s12884-022-04505-5 Open DOISearch in Google Scholar

29. Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Håberg SE. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. N Engl J Med. 2021;385(21):2008–2010. doi: 10.1056/NEJMc2114466 MagnusMC GjessingHK EideHN WilcoxAJ FellDB HåbergSE Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage N Engl J Med 2021 385 21 2008 2010 10.1056/NEJMc2114466 Open DOISearch in Google Scholar

30. Moro PL, Olson CK, Clark E, Marquez P, Strid P, Ellington S, et al. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021. Vaccine. 2022;40(24):3389–94. doi: 10.1016/j.vaccine.2022.04.031 MoroPL OlsonCK ClarkE MarquezP StridP EllingtonS Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021 Vaccine 2022 40 24 3389 94 10.1016/j.vaccine.2022.04.031 Open DOISearch in Google Scholar

31. Yang YJ, Murphy EA, Singh S, Sukhu AC, Wolfe I, Adurty S, et al. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Obstet Gynecol. 2022;139(3):373–80. doi: 10.1097/AOG.0000000000004693 YangYJ MurphyEA SinghS SukhuAC WolfeI AdurtyS Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery Obstet Gynecol 2022 139 3 373 80 10.1097/AOG.0000000000004693 Open DOISearch in Google Scholar